“[Lucemyra] is important because of the impact it has on the opioid epidemic. We’re proud of being part of the community that’s helping save lives,” she says.
“Maybe it’s a bit of an exaggeration, but I believe our work has a strong impact on what’s going on in the world.”
The 5-year-old agency picked up three other assignments in 2017, including work on Mist Pharmaceuticals’ new erectile dysfunction treatment Stendra, Mylan’s respiratory drug Perforomist, and Bayer’s antibiotic Amikacin. Silverlight’s healthcare revenue jumped nearly 12% during 2017, increasing from $4.2 million to $4.7 million.
Goldberg says the growth exceeded expectations, though she adds “it becomes harder to keep hitting these double-digit growth numbers.”
The lion’s share of that growth came from existing clients that, Goldberg notes, spent more and expanded their relationships with the agency in 2017.
Still, Silverlight lost four pharma accounts during the year, which Goldberg attributes to factors related to Silverlight’s partner agencies. She explains Silverlight often partners with other firms. When those firms stop working with a shared client, so does Silverlight.
In the wake of the agency’s recent growth, Goldberg notes its biggest challenge has become finding and retaining the right people. It reported 25 full-timers at the end of 2017, up just two from the end of 2016. Both additions came at the director level: media director Stephen Wraspir, from UM Worldwide, and search director Meredith Hughes, formerly with Analytics Pros and SoMe Connect.
“We want to make sure we’re providing the people who have the customer service hat on first, but also people who understand the pharma industry and make sure that for every dollar we spend there’s a positive ROI,” Goldberg says.
Silverlight further expanded its professional capabilities in 2017 with the debut of a practice focused on point-of-care marketing.
Four of the agency’s clients are already taking advantage of the new offering, Goldberg reports, which is often lumped in with out-of-home advertising at other agencies.